Wikipedia -WSS

Wikipedia

author：explore 2025-10-01 04:11:24 - browse：42

research funding, medical devices — APStock

WASHINGTON — A federal district judge on Monday granted the Biden administration’s request to dismiss a lawsuit challenging Medicare’s new drug price negotiation program from the drug industry lobbying organization PhRMA.

The move is an early but positive sign for the Biden administration in a legal fight that could stretch for years, as a host of major drugmakers, including Merck, Bristol Myers Squibb, and Johnson & Johnson, have also filed lawsuits over the constitutionality of Medicare’s new powers. The first round of drug negotiations is ongoing, and a judge heard oral arguments in a challenge brought by AstraZeneca just last month.

Newsletters

Sign up for D.C. Diagnosis

Washington never stops. Cut through the noise with our essential updates on health care politics and policy

Please enter a valid email address. Privacy Policy

The National Infusion Center Association and the Global Colon Cancer Association are also plaintiffs in PhRMA’s lawsuit. The judge dismissed the National Infusion Center Association from the case because it did not have subject matter jurisdiction to bring the lawsuit. And because NICA was the only party to the lawsuit that resides in Texas, the judge tossed out the case in its entirety.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： As demand for Covid shots wanes, Moderna seeks its next success
Next article： There's an unseen cost to disruptive road

entertainment

hotspot

WSS

FDA's naming rule on biosimilars has undermined competition

Dog Aging Project founders on what lies ahead after losing funding

Maisha Meds is a PBM, but don't call it that

Patient advocates debate FDA's accelerated approval process

There's an unseen cost to disruptive road

Medicare drug price lawsuits could be good politics for Biden

knowledge

Wikipedia

Sign up for D.C. Diagnosis

hotspot

Continuity nursing helped my family in our darkest PICU moments

Maisha Meds is a PBM, but don't call it that

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Readout LOUD podcast: mifepristone case, GLP

As demand for Covid shots wanes, Moderna seeks its next success

TikTok, Instagram influencers need more rules for drug ads

Alkermes shareholders re

Patient advocates debate FDA's accelerated approval process

Trump demands the U.S. pay no more for drugs than other countries … again

Dana Farber says 6 studies to be retracted and 31 corrected

leisure time

Printout prescription drug information shouldn’t go digital

FDA sets aggressive timeline for overhauling inspection procedures

Sanofi to acquire U.S. biotech Inhibrx in $2.2 billion deal

Readout Newsletter: Blackstone Life Sciences, Merck, Bluebird Bio

What causes osteoarthritis? Researchers study link to brain protein

Food as medicine: Medically tailored meals may get standardized

entertainment

leisure time

hotspot

explore